Elafin is a Biomarker of Graft Versus Host Disease of the Skin
Sophie Paczesny(MUSC Hollings Cancer Center), James L.M. Ferrara(Tisch Hospital), A. Chin(Fred Hutch Cancer Center), Joel Whitfield(University of Michigan), H. Wang(Fred Hutch Cancer Center), Jeffrey Crawford(Duke Medical Center), Samir Hanash(The University of Texas MD Anderson Cancer Center), John E. Levine(Icahn School of Medicine at Mount Sinai), Vítor M. Faça(Universidade de Ribeirão Preto), David B. Jones(James Cook University), Sung Won Choi(University of Michigan), Shin Mineishi(University of Alabama at Birmingham), Carrie L. Kitko(Vanderbilt University Medical Center), Pavan Reddy(Wichita State University), Q. Zhang(Fred Hutch Cancer Center), Thomas Braun(University of Michigan), Jason M. Hogan(Fred Hutch Cancer Center), Oleg I. Krijanovski, Sharon J. Pitteri(Oregon Health & Science University)
Cited by 7
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945